skip to main content
Show Results with:

Adjuvant ribavirin and longer direct‐acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure

Lu, Mei et al.

Journal of viral hepatitis. Volume 26:Number 10 (2019, October); pp 1210-1217 -- Wiley

Online access

Searching Remote Databases, Please Wait